Heart
and vascular disease is the #1 killer throughout the world for men, women and
children. A death from heart or vascular
disease occurs every 33 seconds, with 2,600 deaths occurring each day, and more
than one million deaths occurring each year. There are 43 million women in the United States at this moment living
with heart or vascular disease. In
contrast, there are 5 million women living with cancer in the US
presently. A woman is 5 times more
likely to die of heart disease than of breast cancer. More women die of heart and vascular disease
than of all cancers combined. A young
person dies on the playing fields in the US every 2 to 3 weeks.
Over the past decade, physicians and scientists have worked diligently
to find ways to combat the various physiological and behavioral risk factors
and the genetic alterations associated with cardiovascular disease. Our one-day
symposium will feature lectures and discussions by distinguished faculty who
will provide current information on the status and future directions of
cardiovascular medicine and surgery. The
faculty will highlight recent progress in the diagnosis and treatment of
cardiovascular disease, as well as new therapeutic modalities.
Target Audience
The audience for this continuing medical education activity includes cardiologists, cardiovascular surgeons, internists, and clinical researchers.
Learning Objectives
At the conclusion of this symposium, participants should be able to -
-
Discuss recent scientific advances in lipid management and the use of statins for acute and chronic coronary artery disease.
-
Review newer pharmacologic platforms for ST elevation MI.
-
Describe advances in the medical and interventional treatment of unstable angina and non-Q wave MI.
-
Determine the appropriate use of CT and MRI/MRA for diagnosing cardiovascular disease.
-
Discuss latest findings related to pathogenesis of hypertrophic cardiomyopathy and its treatment.
-
Cite new surgical options with robotic surgery, and its role in modern-day surgical practice.
-
Assess the latest surgical devices available to treat acute, decompensated heart failure patients.
-
Recognize the potential therapeutic options with stem cell therapy for cardiovascular disease including congestive heart failure.
-
Highlight new advances in electrophysiology, including biventricular pacing, defibrillation, and ablation.
-
Discuss how genetic discovery is being used to identify patients at risk for premature MIs.
-
Identify specific PCI characteristics that are associated with a higher risk of very late complications, including stent thrombosis.
-
Discuss the use of stem cell therapy in the regeneration of damaged heart tissue.
Faculty
Blase Carabello, MD
Benjamin Cheong, MD
R. David Fish, MD
O.H. Frazier, MD
Peter H. Jones, MD
Hari Mallidi, MD
A.J. Marian, MD
Ali Massumi, MD
Deborah Meyers, MD
Dianna Milewicz, MD, PhD
Emerson C. Perin, MD, PhD
George J. Reul, MD
James T. Willerson, MD - Program Director
James M. Wilson, MD
Program Schedule
Friday December 7, 2012
SESSION I
7:00 a.m. Continental Breakfast
7:30 a.m. Welcome and Introductions
James T. Willerson, MD
7:45 a.m. Lipid Advances: New Guidelines,
Risk Assessment and Future Treatments
Peter H. Jones, MD
8:15 a.m. Advances in the Medical Treatment of
Unstable Angina and Non-Q Wave MI
James T. Willerson, MD
8:45 a.m. Advances in Interventional Cardiology
R. David Fish, MD
9:15 a.m. Advances in the Treatment of ST Elevation MI
James M. Wilson, MD
9:45 a.m. Break
SESSION II
10:00 a.m. Advances in CT and MRI/MRA to
Recognize Cardiovascular Disease
Benjamin Cheong, MD
10:30 a.m. Advances in the Treatment of
Valvular Heart Disease
Blase Carabello, MD
11:00 a.m. Latest in Electrophysiology Procedures
Ali Massumi, MD
11:30 a.m. Stem Cell Therapy in the Treatment of CHF
and Cardiovascular Disease
Emerson C. Perin, MD, PhD
12:00 p.m. To Atrium for Presentation of
Ray C. Fish Award and Luncheon
SESSION III
12:15 p.m. Introduction of the Ray C. Fish Award
and Recipient
Denton A. Cooley, MD and James T. Willerson, MD
12:25 p.m. Presentation of the Ray C. Fish Award
Denton A. Cooley, MD and James T. Willerson, MD
12:30 p.m. Luncheon in honor of Ray C. Fish Award Recipient
1:20 p.m. To Auditorium for continuation of symposium
1:30 p.m. Ray C. Fish Lecture
George J. Reul, MD
SESSION IV
2:00 p.m. Advances in the Medical Treatment of CHF
Deborah Meyers, MD
2:30 p.m. Advances in the Surgical Treatment of CHF
O.H. Frazier, MD
3:00 p.m. Break
3:15 p.m. Advances in Surgical Treatment of Acute
and Chronic CAD
Hari Mallidi, MD
3:45 p.m. Gene Discoveries in Identifying Patients
at Risk for Premature MIs
Dianna M. Milewicz, MD, PhD
4:15 p.m. Hypertrophic Cardiomyopathy and its Treatment
A.J. Marian, MD
4:45 p.m. Final Comments and Adjourn
James T. Willerson, MD
|
